Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4767)
All Articles published online
|
Publishing Process of This Article
|
Oct 16, 2022 (publication date) through Aug 9, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang Z, Zheng CQ. Vedolizumab in the treatment of immune checkpoint inhibitor-induced colitis: Two case reports. World J Clin Cases 2022; 10(29): 10550-10558 [PMID: 36312501 DOI: 10.12998/wjcc.v10.i29.10550] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i29/10550.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Qian Hao, Wenwen Zhu, Qingqing Guo, Xiuxiu Lu, Shijun Zhang, Jianjun Yang, Zhonghua Song. Sintilimab-induced intestinal obstruction and hemorrhage of the digestive tract: a case report. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1590714
|